NCT04881019Active, not recruiting
PRediction Of Glycemic RESponse Study
Prediction of Glycemic Response Study (PROGRESS)
Source: ClinicalTrials.gov · Last updated 21 May 2025
Brief summary (registry, in English)
The purpose of PROGRESS is to engage and intensively monitor 1000 individuals' dietary intake, activity levels, and continuous glucose values over 10 days, link to clinical events out to 3-years, and use that data along with genomic, microbiome, electronic health record (EHR), and other biomarker data to develop a predictive model of individual glucose responses to nutrient intake in individuals with and without type 2 diabetes.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1070 (actual)
- First submitted
- 6 May 2021
- Start date
- 8 Jun 2021
- Primary completion date
- 1 Sept 2023
- Lead sponsor
- Scripps Translational Science Institute
- Diseases
- Type 2 diabetes
- NCT number
- NCT04881019
What you commit to
- Study type: Observational
- Participants enrolled: 1070
- From 8 Jun 2021 to the primary completion date, 1 Sept 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior bariatric surgery
- Antibiotic use in the last 3 months prior to the start of the study or planned use during the duration of the study
Other illness
- Type 1 diabetes mellitus
- Chemotherapy or radiation treatment for cancer in the past year
- Inflammatory bowel disease
- End stage renal disease
Lab values
- Known skin allergy to adhesives and nickel (or other contraindications to continuous glucose monitoring)
- Currently taking any oral steroids(these medications may impact glucose levels)
Other
- Unable to participate in or comply with any of the testing modules asked during the study
- Currently pregnant
- Non-dietary, supplemental probiotic use either daily or weekly
- Hospice care
Who the study is looking for
- Age ≥ 18 years.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Scripps Research Translational Institute Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.